Search research articles
Contact Us
Filters
Showing results (21-30 of 36) with videos related to
Page
of 4
Sort By:
Molecules (Basel, Switzerland)
|
July 29, 2023
Computational Studies on Microreactors for the Decomposition of Formic Acid for Hydrogen Production Using Heterogeneous Catalysts
Eleana Harkou, Panayiota Adamou, Kyproula Georgiou, et al.
Psychopharmacology
|
September 6, 2006
Intramuscular aripiprazole for the treatment of acute agitation in patients with schizophrenia or schizoaffective disorder: a double-blind, placebo-controlled comparison with intramuscular haloperidol
Raisa Andrezina, Richard C Josiassen, Ronald N Marcus, et al.
The Journal of Clinical Psychiatry
|
August 5, 2011
Safety and tolerability of aripiprazole for irritability in pediatric patients with autistic disorder: a 52-week, open-label, multicenter study
Ronald N Marcus, Randall Owen, George Manos, et al.
The Primary Care Companion for CNS Disorders
|
July 7, 2011
Safety and tolerability of aripiprazole in the treatment of irritability associated with autistic disorder in pediatric subjects (6-17 years old):results from a pooled analysis of 2 studies
Adelaide S Robb, Candace Andersson, Elizabeth E Bellocchio, et al.
Dalton Transactions (Cambridge, England : 2003)
|
July 14, 2004
The design of a continuous reactor for fluorous biphasic reactions under pressure and its use in alkene hydroformylation
Evangelia Perperi, Yulin Huang, Panagiota Angeli, et al.
Journal of Psychiatric Practice
|
May 25, 2007
Intramuscular aripiprazole in the control of agitation
Glenn W Currier, Leslie L Citrome, Dan L Zimbroff, et al.
Pediatrics
|
December 2, 2009
Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder
Randall Owen, Linmarie Sikich, Ronald N Marcus, et al.
Journal of Psychiatric Practice
|
May 25, 2007
Efficacy and safety of oral aripiprazole compared with haloperidol in patients transitioning from acute treatment with intramuscular formulations
David G Daniel, Glenn W Currier, Dan L Zimbroff, et al.
Journal of Child and Adolescent Psychopharmacology
|
June 14, 2011
Aripiprazole in the treatment of irritability in pediatric patients (aged 6-17 years) with autistic disorder: results from a 52-week, open-label study
Ronald N Marcus, Randall Owen, George Manos, et al.
Environmental Research
|
July 28, 2023
Different reactor configurations for enhancement of CO<sub>2</sub> methanation
Eleana Harkou, Sanaa Hafeez, Panayiota Adamou, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 36) with videos related to
Sort By:
Page
of 4
Molecules (Basel, Switzerland)
|
July 29, 2023
Computational Studies on Microreactors for the Decomposition of Formic Acid for Hydrogen Production Using Heterogeneous Catalysts
Eleana Harkou, Panayiota Adamou, Kyproula Georgiou, et al.
Psychopharmacology
|
September 6, 2006
Intramuscular aripiprazole for the treatment of acute agitation in patients with schizophrenia or schizoaffective disorder: a double-blind, placebo-controlled comparison with intramuscular haloperidol
Raisa Andrezina, Richard C Josiassen, Ronald N Marcus, et al.
The Journal of Clinical Psychiatry
|
August 5, 2011
Safety and tolerability of aripiprazole for irritability in pediatric patients with autistic disorder: a 52-week, open-label, multicenter study
Ronald N Marcus, Randall Owen, George Manos, et al.
The Primary Care Companion for CNS Disorders
|
July 7, 2011
Safety and tolerability of aripiprazole in the treatment of irritability associated with autistic disorder in pediatric subjects (6-17 years old):results from a pooled analysis of 2 studies
Adelaide S Robb, Candace Andersson, Elizabeth E Bellocchio, et al.
Dalton Transactions (Cambridge, England : 2003)
|
July 14, 2004
The design of a continuous reactor for fluorous biphasic reactions under pressure and its use in alkene hydroformylation
Evangelia Perperi, Yulin Huang, Panagiota Angeli, et al.
Journal of Psychiatric Practice
|
May 25, 2007
Intramuscular aripiprazole in the control of agitation
Glenn W Currier, Leslie L Citrome, Dan L Zimbroff, et al.
Pediatrics
|
December 2, 2009
Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder
Randall Owen, Linmarie Sikich, Ronald N Marcus, et al.
Journal of Psychiatric Practice
|
May 25, 2007
Efficacy and safety of oral aripiprazole compared with haloperidol in patients transitioning from acute treatment with intramuscular formulations
David G Daniel, Glenn W Currier, Dan L Zimbroff, et al.
Journal of Child and Adolescent Psychopharmacology
|
June 14, 2011
Aripiprazole in the treatment of irritability in pediatric patients (aged 6-17 years) with autistic disorder: results from a 52-week, open-label study
Ronald N Marcus, Randall Owen, George Manos, et al.
Environmental Research
|
July 28, 2023
Different reactor configurations for enhancement of CO<sub>2</sub> methanation
Eleana Harkou, Sanaa Hafeez, Panayiota Adamou, et al.
Page
of 4